Related references
Note: Only part of the references are listed.Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase
Qi Xiong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Update 2021: Management of Small Cell Lung Cancer
Sara Tariq et al.
LUNG (2021)
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab
Edoardo Lenci et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis
Ye Qiu et al.
FRONTIERS IN ONCOLOGY (2021)
Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab
Wei-Xiang Qi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer
Sho Matsubara et al.
PLOS ONE (2021)
Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients
Yifang Shui et al.
Aging-US (2021)
Small cell lung cancer: a slightly less orphan disease after immunotherapy
J. Remon et al.
ANNALS OF ONCOLOGY (2021)
Significance of a preoperative systemic immune-inflammation index as a predictor of postoperative survival outcomes in gastric cancer
Hiroyuki Inoue et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer
Satoshi Katayama et al.
WORLD JOURNAL OF UROLOGY (2021)
Prognostic Significance of Systemic Immune-Inflammation Index in Patients With Diffuse Large B-Cell Lymphoma
Zanzan Wang et al.
FRONTIERS IN ONCOLOGY (2021)
Evaluation of diagnostic and predictive values of the serum VEGF-A level and systemic immune-inflammation index in small cell lung cancer
Jing-hao Yao et al.
JOURNAL OF CANCER (2021)
Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer
Pranav Murthy et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy
Li Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy
Chunyan Wang et al.
LUNG (2020)
Immunotherapeutic approaches for small-cell lung cancer
Wade T. Iams et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer
Ali Yilmaz et al.
LUNG (2020)
Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis
Yantao Zhang et al.
CANCER CELL INTERNATIONAL (2020)
Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab
Jingjing Liu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2019)
The predictive effect of the systemic immune-inflammation index for patients with small-cell lung cancer
Duoying Wang et al.
FUTURE ONCOLOGY (2019)
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer
Rossana Berardi et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
The prognostic value of systemic immune-inflammation index (SII) in patients after radical operation for carcinoma of stomach in gastric cancer
Qingshan Wang et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Prognostic and predictive value of tumor in early breast cancer
Carmen Criscitiello et al.
CANCER TREATMENT REVIEWS (2016)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
Systemic Immune-inflammation Index, Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for Predicting Prognosis in Small Cell Lung Cancer
Xuan Hong et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Platinum versus non-platinum chemotherapy regimens for small cell lung cancer
Isuru U. Amarasena et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology
Katerina Pilatova et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Tumor-Infiltrating Immune Cells Promoting Tumor Invasion and Metastasis: Existing Theories
Yan-gao Man et al.
JOURNAL OF CANCER (2013)
The platelet contribution to cancer progression
N. M. Bambace et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)